NRG Oncology adds new leadership members to Developmental Therapeutics, Patient Centered Outcomes Research, Protocol Operations Management, Head and Neck Cancer, and Translational Science committees - EurekAlert!
The advent of nanotechnology has ushered in a transformative era for oncology, offering unprecedented capabilities for targeted drug delivery and controlled release. This paradigm shift enhances therapeutic efficacy while mitigating the debilitating side - EurekAlert!
AI agents for oncology: Dresden research team develops system to support clinical decisions - EurekAlert!
NCCN recognizes outstanding contributions in oncology with 2025 awards - EurekAlert!
NCCN Policy Summit builds bridges between primary care and oncology for better cancer outcomes - EurekAlert!
AI meets oncology: New model personalizes bladder cancer treatment - EurekAlert
AI meets oncology: New model personalizes bladder cancer treatment
NRG Oncology and Flatiron Health announce col - EurekAlert
Leading computational scientist & oncology re - EurekAlert
Cancer Vaccine Breakthrough: How Tiny Proteins Could Revolutionize Oncology
Revolutionizing Oncology: A Non-Invasive Cancer GPS for Tumor Malignancy Assessment
Revolutionizing Oncology: Synchrotron X-Rays Expose Cancer’s Protein Weaknesses
Revolutionizing Oncology: T Cells As Predictive Powerhouses in Skin Cancer
Mathematics supporting fresh theoretical approach in oncology
New branch of oncology, cancer neuroscience, offers hope for hard-to-treat brain tumors
